Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare ...

Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

Eli Lilly's weight-loss therapy Mounjaro became India's top-selling drug by value in October, data showed on Friday, ...

(Reuters) -U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo ...

The drugmaker said it would launch late-stage trials of the drug after participants lost as much as 20% of their body weight.

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

The White House is nearing an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their ...

David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...